Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Variation in KLK genes, prostate-specific antigen and risk of prostate cancer

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Associations of tag SNPs in the KLK region with PSA concentrations and prostate cancer risk in the PLCO Trial.

References

  1. Eeles, R.A. et al. Nat. Genet. 40, 316–321 (2008).

    Article  CAS  Google Scholar 

  2. Pal, P. et al. Hum. Genet. 122, 251–259 (2007).

    Article  CAS  PubMed  Google Scholar 

  3. Lai, J. et al. Carcinogenesis 28, 1032–1039 (2007).

    Article  CAS  PubMed  Google Scholar 

  4. Cramer, S.D. et al. J. Natl. Cancer Inst. 95, 1044–1053 (2003).

    Article  CAS  PubMed  Google Scholar 

  5. Prorok, P.C. et al. Control. Clin. Trials 21, 273S–309S (2000).

    Article  CAS  PubMed  Google Scholar 

  6. Thomas, G. et al. Nat. Genet. 40, 310–315 (2008).

    Article  CAS  Google Scholar 

  7. Borgono, C.A. et al. Mol. Cancer Res. 2, 257–280 (2004).

    CAS  PubMed  Google Scholar 

  8. Woolf, S.H. N. Engl. J. Med. 333, 1401–1405 (1995).

    Article  CAS  PubMed  Google Scholar 

  9. de Koning, H.J. et al. Int. J. Cancer 98, 268–273 (2002).

    Article  CAS  PubMed  Google Scholar 

  10. Nam, R.K. et al. J. Clin. Oncol. 21, 2312–2319 (2003).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics and by contracts from the Division of Cancer Prevention, National Cancer Institute (NCI), US National Institutes of Health (NIH), Department of Health and Human Services (DHHS). The Health Professionals Follow-up Study (HPFS) study is supported by NIH grants CA55075 and U01CA098233. The American Cancer Society (ACS) study is supported by U01 CA098710. The Alpha Tocopherol Beta-Carotene Cancer Prevention (ATBC) Study is supported by the Intramural Research Program of the National Cancer Institute, NIH, and by US Public Health Service contracts N01-CN-45165, N01-RC-45035 and N01-RC-37004 from the National Cancer Institute, NIH, DHHS. A.S.K is supported by RO1CA112028. The genome-wide scans have been supported by the NCI, NIH, under contract N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the DHHS, nor does mention of trade names, commercial products or organizations imply endorsement by the US government.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard B Hayes.

Supplementary information

Supplementary Text and Figures

Supplementary Figure 1, Supplementary Tables 1–6, Supplementary Methods (PDF 418 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ahn, J., Berndt, S., Wacholder, S. et al. Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Nat Genet 40, 1032–1034 (2008). https://doi.org/10.1038/ng0908-1032

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng0908-1032

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing